Member Info for Rob23460

Well fingers crossed it really is Goodbye !!!!

A very nice RNS to welcome our new CEO !!!!

Morning Laura ....who is Diggle . Martin Diggle

CO-FOUNDER AND CHAIRMAN OF VULPES INVESTMENT MANAGEMENT UK LTD

I guess in due course we will find out exactly who the fools are !!!

No criticism Miavoice !!!!

Thanks Miavoice for your effort's....I don't know about anybody else but I'm having to re-listen again and again to JMC comments with regards to his accent.

I wondered the same WTP ......is there more to come by Friday?

I don't know if the buyer is back but you could sell circa 400,000 of the bat @13.30 for the last few hrs trading !!!!

Scinv_temp...... Lindy lied that's a very strong claim !!!!

Lse1111 does it show how many units purchased ?

EE fair enough I stand corrected !

Well I'm not sure if it's significant or not but you are correct Samantha Paston was advertised as a speaker last Thursday when I checked. I have checked again tonight and Lindy has reappeared as speaker.

Dr Paul Mulholland, a brain cancer specialist at University College London – and it has proved remarkably successful.

The breakthrough treatment plan uses ipilimumab – an immunotherapy drug given intravenously that is already used on the NHS to treat skin cancer – to first shrink the tumour.

The drug 'takes the breaks off the immune system', according to experts, helping it seek out and destroy cancerous cells wherever they are.

Cleaner here are a few details from the article

Potentially they could of course so better to sell now dont you think !!

Keithbfk ..........Agreed

Make that 9k sold now !!

And at No 2 in the Most Wished For category

KonarA agreed they appear quietly confident as to where revenue is going to come from as per Sath's statement !!!

When you consider that statement and if it becomes a reality not bad from a minnow of a biotech company in comparison to many others!!!

BOJO...... I was asking myself the same question I've looked on the website and I cant work out how to listen to the webcast.